COMMUNIQUÉS West-GlobeNewswire

Erratum: Correction du communiqué de presse publié le 7 avril 2026
09/04/2026
Le communiqué de presse publié le 7 avril 2026, relatif à l’acquisition d’actions propres, contenait les erreurs suivantes : Au troisième paragraphe, le nombre d’actions rachetées doit être “32.000 ” au lieu de “16.000 [...]
USA Today Names Aledade a 2026 Top Workplace for People-First Culture
09/04/2026
National award honors Aledade’s commitment to employee engagement and its mission-driven approach to advancing value-based care BETHESDA, Md., April 09, 2026 (GLOBE NEWSWIRE) -- Aledade , a physician-led, national [...]
Novo Nordisk A/S: Wegovy® injection becomes first GLP-1 weight-loss treatment approved for 48-hour controlled-temperature delivery in the EU
09/04/2026
The European Medicines Agency (EMA) has approved an update to the product information of Wegovy ® injection, allowing it to be delivered to patients at controlled temperatures of up to 30°C for up to 48 hours This makes [...]
NKGen Biotech to Present Troculeucel Mechanism Data in Alzheimer’s and Frontotemporal Dementia at the Neuroimmunology Drug Development Summit
09/04/2026
SANTA ANA, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative [...]
Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026
09/04/2026
SEATTLE, April 09, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results [...]
Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner
09/04/2026
KIRKLAND, Wash., April 09, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced it has been named a 2026 USA TODAY [...]
Onconetix Highlights Realbotix's Launch of Vinci AI Vision System with Delivery of First Vinci-Equipped Humanoid Robot to Ericsson
09/04/2026
Vinci Enables Realbotix Robots to Recognize People, Recall Conversations, and Track Engagement; Onconetix Recently Entered into a Definitive Agreement to Acquire Realbotix LLC, a Subsidiary of Realbotix Corp. CINCINNATI [...]
Cloudbreak Pharma Announces Launch of Cloudbreakpharma.com to Raise Awareness of its Pipeline of Novel First-in-Class Therapeutics to Treat Serious Underserved Ophthalmic Diseases
09/04/2026
Lead candidate, CBT-001 for the treatment of pterygium, a multi-billion-dollar addressable market, is in mid-Phase 3 with initial topline data anticipated in Q3 2026 Second asset, CBT-004 for the treatment of pinguecula [...]
Fedora Pharmaceuticals Showcasing Antibiotic Candidate at 2026 European Society of Clinical Microbiology and Infectious Diseases Congress
09/04/2026
EDMONTON, Alberta , April 09, 2026 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat antibiotic-resistant infections, intends to present a full suite of preclinical findings [...]
Noom and b.well Partner to Launch Integrated Health Record Access for Medicare Members
09/04/2026
New integration delivers on Noom's pledge to the CMS Health Technology Ecosystem initiative to enable deeper personalization within Noom’s diabetes and obesity programs PRINCETON, N.J., April 09, 2026 (GLOBE NEWSWIRE [...]
Highridge Medical Enters Exclusive Distribution Agreement for the Waypoint GPS Enabling Technology Platform
09/04/2026
Highridge portfolio expands to include an innovative pedicle probe with real-time visual feedback. WESTMINSTER, Colo., April 09, 2026 (GLOBE NEWSWIRE) -- Highridge Medical, a leading privately held global spine company [...]
Cerevance to Present Positive Phase 2 Solengepras Data in Parkinson’s Disease at the American Academy of Neurology 2026 Annual Meeting
09/04/2026
Solengepras, a once-daily, oral, non-dopaminergic GPR6 inhibitor, demonstrated meaningful reductions in daily OFF time and improvements in sleep-related symptoms across two Phase 2 trials Meeting presentations highlight [...]
Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples
09/04/2026
Seer’s Proteograph will be used to generate enhanced proteomic insights in one of the world’s largest multi-omic health studies REDWOOD CITY, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the [...]
Beech Acres Parenting Center Wins Seven National Top Workplaces Awards, Including Nonprofit Industry and Culture Excellence Awards
09/04/2026
CINCINNATI, April 09, 2026 (GLOBE NEWSWIRE) -- Beech Acres Parenting Center, where highly engaged and supported staff inspire and equip today’s parents, families and communities to raise capable, resilient and [...]
Sparian Biosciences Announces Initiation of Phase 1 Clinical Trial of SBS-147 Next Generation Arylepoxamide Agonist for the Treatment of Pain Funded by a $15M NIH Grant
09/04/2026
Phase 1 clinical trial will evaluate the safety, tolerability, and pharmacokinetics SBS-147 is a novel and potent oral analgesic with a differentiated safety profile being developed for acute and chronic pain The phase [...]
Spectral AI to Feature DeepView® System at 2026 American Burn Association Annual Meeting
09/04/2026
DeepView System will be on Display at Booth #601 DALLAS, April 09, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical [...]
Annovis Announces $10 Million Underwritten Offering of Common Stock and Accompanying Warrants
09/04/2026
MALVERN, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for [...]
Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%
09/04/2026
Important ophthalmic treatment expected to be an important growth driver for Amneal’s Affordable Medicines segment BRIDGEWATER, N.J., April 09, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “ [...]
Alignment Healthcare to Announce First Quarter 2026 Financial Results and Host Conference Call Thursday, April 30, 2026
09/04/2026
ORANGE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its first quarter 2026 financial results on Thursday, April 30, 2026, after market close. Following the release [...]

Pages